Selected research
Industry Research
AI-based Diabetic Eye Disease Screening System Industry Research Report 2026
Market perspective
The global AI-based Diabetic Eye Disease Screening System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI-based Diabetic Eye Disease Screening System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI-based Diabetic Eye Disease Screening System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI-based Diabetic Eye Disease Screening System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI-based Diabetic Eye Disease Screening System include Remidio, Retmarker, VoxelCloud, Airdoc, Zhiyuan Huitu, IDx, LLC, Zhenhealth, Eyenuk and AEYE Health and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI-based Diabetic Eye Disease Screening System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI-based Diabetic Eye Disease Screening System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI-based Diabetic Eye Disease Screening System Market by Company
Remidio
Retmarker
VoxelCloud
Airdoc
Zhiyuan Huitu
IDx, LLC
Zhenhealth
Eyenuk
AEYE Health
Optomed
AI-based Diabetic Eye Disease Screening System Segment by Type
On-premise
Cloud-based
Hybrid Mode
AI-based Diabetic Eye Disease Screening System Segment by Application
General Hospitals
Ophthalmology Hospitals
Diabetes Specialty Hospitals
AI-based Diabetic Eye Disease Screening System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-based Diabetic Eye Disease Screening System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-based Diabetic Eye Disease Screening System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-based Diabetic Eye Disease Screening System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI-based Diabetic Eye Disease Screening System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-premise
- Cloud-based
- Hybrid Mode
Applications
- General Hospitals
- Ophthalmology Hospitals
- Diabetes Specialty Hospitals
Companies covered
- Remidio
- Retmarker
- VoxelCloud
- Airdoc
- Zhiyuan Huitu
- IDx, LLC
- Zhenhealth
- Eyenuk
- AEYE Health
- Optomed
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI-based Diabetic Eye Disease Screening System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-premise
- 2.2.3 Cloud-based
- 2.2.4 Hybrid Mode
- 2.3 AI-based Diabetic Eye Disease Screening System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 General Hospitals
- 2.3.3 Ophthalmology Hospitals
- 2.3.4 Diabetes Specialty Hospitals
- 2.4 Assumptions and Limitations
3 AI-based Diabetic Eye Disease Screening System Breakdown Data by Type
- 3.1 Global AI-based Diabetic Eye Disease Screening System Historic Market Size by Type (2021-2026)
- 3.2 Global AI-based Diabetic Eye Disease Screening System Forecasted Market Size by Type (2027-2032)
4 AI-based Diabetic Eye Disease Screening System Breakdown Data by Application
- 4.1 Global AI-based Diabetic Eye Disease Screening System Historic Market Size by Application (2021-2026)
- 4.2 Global AI-based Diabetic Eye Disease Screening System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI-based Diabetic Eye Disease Screening System Market Perspective (2021-2032)
- 5.2 Global AI-based Diabetic Eye Disease Screening System Growth Trends by Region
- 5.2.1 Global AI-based Diabetic Eye Disease Screening System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI-based Diabetic Eye Disease Screening System Historic Market Size by Region (2021-2026)
- 5.2.3 AI-based Diabetic Eye Disease Screening System Forecasted Market Size by Region (2027-2032)
- 5.3 AI-based Diabetic Eye Disease Screening System Market Dynamics
- 5.3.1 AI-based Diabetic Eye Disease Screening System Industry Trends
- 5.3.2 AI-based Diabetic Eye Disease Screening System Market Drivers
- 5.3.3 AI-based Diabetic Eye Disease Screening System Market Challenges
- 5.3.4 AI-based Diabetic Eye Disease Screening System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI-based Diabetic Eye Disease Screening System Players by Revenue
- 6.1.1 Global Top AI-based Diabetic Eye Disease Screening System Players by Revenue (2021-2026)
- 6.1.2 Global AI-based Diabetic Eye Disease Screening System Revenue Market Share by Players (2021-2026)
- 6.2 Global AI-based Diabetic Eye Disease Screening System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI-based Diabetic Eye Disease Screening System Head Office and Area Served
- 6.4 Global AI-based Diabetic Eye Disease Screening System Players, Product Type & Application
- 6.5 Global AI-based Diabetic Eye Disease Screening System Manufacturers Established Date
- 6.6 Global AI-based Diabetic Eye Disease Screening System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 7.2 North America AI-based Diabetic Eye Disease Screening System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 7.4 North America AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 8.2 Europe AI-based Diabetic Eye Disease Screening System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 8.4 Europe AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 9.2 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 10.2 South America AI-based Diabetic Eye Disease Screening System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 10.4 South America AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size (2021-2032)
- 11.2 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI-based Diabetic Eye Disease Screening System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Remidio
- 12.1.1 Remidio Company Information
- 12.1.2 Remidio Business Overview
- 12.1.3 Remidio Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.1.4 Remidio AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.1.5 Remidio Recent Developments
- 12.2 Retmarker
- 12.2.1 Retmarker Company Information
- 12.2.2 Retmarker Business Overview
- 12.2.3 Retmarker Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.2.4 Retmarker AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.2.5 Retmarker Recent Developments
- 12.3 VoxelCloud
- 12.3.1 VoxelCloud Company Information
- 12.3.2 VoxelCloud Business Overview
- 12.3.3 VoxelCloud Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.3.4 VoxelCloud AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.3.5 VoxelCloud Recent Developments
- 12.4 Airdoc
- 12.4.1 Airdoc Company Information
- 12.4.2 Airdoc Business Overview
- 12.4.3 Airdoc Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.4.4 Airdoc AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.4.5 Airdoc Recent Developments
- 12.5 Zhiyuan Huitu
- 12.5.1 Zhiyuan Huitu Company Information
- 12.5.2 Zhiyuan Huitu Business Overview
- 12.5.3 Zhiyuan Huitu Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.5.4 Zhiyuan Huitu AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.5.5 Zhiyuan Huitu Recent Developments
- 12.6 IDx, LLC
- 12.6.1 IDx, LLC Company Information
- 12.6.2 IDx, LLC Business Overview
- 12.6.3 IDx, LLC Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.6.4 IDx, LLC AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.6.5 IDx, LLC Recent Developments
- 12.7 Zhenhealth
- 12.7.1 Zhenhealth Company Information
- 12.7.2 Zhenhealth Business Overview
- 12.7.3 Zhenhealth Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.7.4 Zhenhealth AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.7.5 Zhenhealth Recent Developments
- 12.8 Eyenuk
- 12.8.1 Eyenuk Company Information
- 12.8.2 Eyenuk Business Overview
- 12.8.3 Eyenuk Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.8.4 Eyenuk AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.8.5 Eyenuk Recent Developments
- 12.9 AEYE Health
- 12.9.1 AEYE Health Company Information
- 12.9.2 AEYE Health Business Overview
- 12.9.3 AEYE Health Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.9.4 AEYE Health AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.9.5 AEYE Health Recent Developments
- 12.10 Optomed
- 12.10.1 Optomed Company Information
- 12.10.2 Optomed Business Overview
- 12.10.3 Optomed Revenue in AI-based Diabetic Eye Disease Screening System Business (2021-2026)
- 12.10.4 Optomed AI-based Diabetic Eye Disease Screening System Product Portfolio
- 12.10.5 Optomed Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst